Target intelligence / Profile preview

Neisseria meningitidis Group B Antigen (MenB Antigen)

Target
MenB Antigen
Molecular classification
Polysaccharide, Outer Membrane Protein, Adhesin, Porin
01

Overview

Neisseria meningitidis group B antigen refers primarily to the capsular polysaccharide and associated surface proteins that define serogroup B of Neisseria meningitidis, a major cause of invasive bacterial disease such as meningitis and sepsis. The capsular polysaccharide is an α(2–8)-linked homopolymer of sialic acid, which mimics human neural cell adhesion molecule (NCAM), leading to poor immunogenicity. Modern vaccines target surface proteins like NadA, fHbp, NHBA, and PorA to induce protective immunity.

Other names
Group B Meningococcal AntigenMenB Capsular PolysaccharideMenB Surface ProteinsNadA (Neisserial adhesin A)fHbp (Factor H binding protein)NHBA (Neisserial heparin binding antigen)PorA
02

Mechanism of action

Induction of bactericidal antibodies against surface antigens, including NadA, fHbp, NHBA, and PorA, leading to complement-mediated killing and opsonophagocytosis of Neisseria meningitidis group B bacteria.

03

Biological functions

Immune evasionAdhesion to host cellsComplement inhibitionInvasion of host tissuesBacterial virulence
04

Disease associations

MeningitisSepsisInvasive Meningococcal Disease (IMD)
05

Safety considerations

Potential for limited cross-protection against diverse strainsRisk of injection site reactionsPotential for eliciting strain-specific immunityAutoimmunity due to molecular mimicry (less of a concern with modern protein-based vaccines)
06

Interacting drugs

4CMenB (Bexsero)

1 more in the full profile.

Beyond the preview

Go deeper on Neisseria meningitidis Group B Antigen (MenB Antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis Group B Antigen (MenB Antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call